# Estradiol as add-on to Antipsychotics

> **NCT04093518** · PHASE3 · UNKNOWN · sponsor: **Tangent Data** · enrollment: 100 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorders

## Interventions

- **DRUG:** Estradiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04093518
- **Lead sponsor:** Tangent Data
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-02
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-11-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-05-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093518, "Estradiol as add-on to Antipsychotics". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04093518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*